Atlas Trials

Rituximab With Corticosteroids Versus Corticosteroids Plus Azathioprine for Moderate-to-Severe Pemphigus Vulgaris

Clinical trial NCT07769333 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07769333
Sponsor
Khyber Teaching Hospital
Status
NOT_YET_RECRUITING
Phase
Early Phase 1
Study type
INTERVENTIONAL
Pemphigus VulgarisRituximab (RTx)
Start date
2026-12-02
Primary completion
2027-05-05
Enrollment
92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.